APHGX | FMDRX | APHGX / FMDRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 12 years | - |
Gain YTD | 2.724 | 2.963 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.36B | 8.89B | 26% |
Annual Yield % from dividends | 0.91 | 1.51 | 60% |
Returns for 1 year | 9.80 | 0.06 | 16,436% |
Returns for 3 years | 10.94 | -7.01 | -156% |
Returns for 5 years | 25.95 | -0.60 | -4,357% |
Returns for 10 years | 61.64 | -2.44 | -2,521% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSCMX | 15.33 | 0.22 | +1.46% |
Morgan Stanley Insight C | |||
ENHNX | 10.57 | 0.06 | +0.57% |
Cullen Enhanced Equity Income I | |||
QLSGX | 28.63 | 0.11 | +0.39% |
Federated Hermes MDT Small Cap Growth R6 | |||
LMGRX | 60.85 | 0.15 | +0.25% |
ClearBridge International Growth R | |||
BSDKX | 14.29 | N/A | N/A |
BlackRock SMID-Cap Growth Equity K |